These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18949559)

  • 1. A simple mathematical model of cytokine capture using a hemoadsorption device.
    DiLeo MV; Kellum JA; Federspiel WJ
    Ann Biomed Eng; 2009 Jan; 37(1):222-9. PubMed ID: 18949559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental validation of a theoretical model of cytokine capture using a hemoadsorption device.
    DiLeo MV; Fisher JD; Federspiel WJ
    Ann Biomed Eng; 2009 Nov; 37(11):2310-6. PubMed ID: 19680812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective improvement of tumor necrosis factor capture in a cytokine hemoadsorption device using immobilized anti-tumor necrosis factor.
    DiLeo MV; Fisher JD; Burton BM; Federspiel WJ
    J Biomed Mater Res B Appl Biomater; 2011 Jan; 96(1):127-33. PubMed ID: 21086427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling competitive cytokine adsorption dynamics within hemoadsorption beads used to treat sepsis.
    Kimmel JD; Harbert EM; Parker RS; Federspiel WJ
    J Chromatogr A; 2011 Nov; 1218(44):8013-20. PubMed ID: 21962329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemofiltration, adsorption, sieving and the challenge of sepsis therapy design.
    Honoré PM; Matson JR
    Crit Care; 2002 Oct; 6(5):394-6. PubMed ID: 12398774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoporous activated carbon beads and monolithic columns as effective hemoadsorbents for inflammatory cytokines.
    Howell CA; Sandeman SR; Phillips GJ; Mikhalovsky SV; Tennison SR; Rawlinson AP; Kozynchenko OP
    Int J Artif Organs; 2013 Oct; 36(9):624-32. PubMed ID: 23918264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing accelerated capture of deoligomerized TNF within hemoadsorption beads used to treat sepsis.
    Kimmel JD; Lacko CS; Delude RL; Federspiel WJ
    J Biomed Mater Res B Appl Biomater; 2011 Jul; 98(1):47-53. PubMed ID: 21504054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hemoadsorption with a novel adsorbent on sepsis: in vivo and in vitro study.
    Zhang J; Peng Z; Maberry D; Volpe J; Kimmel JD; Federspiel WJ; Kellum JA
    Blood Purif; 2015; 39(1-3):239-245. PubMed ID: 25833160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility study of cytokine removal by hemoadsorption in brain-dead humans.
    Kellum JA; Venkataraman R; Powner D; Elder M; Hergenroeder G; Carter M
    Crit Care Med; 2008 Jan; 36(1):268-72. PubMed ID: 18090355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous plasma filtration coupled with sorbents.
    Tetta C; Cavaillon JM; Camussi G; Lonnemann FG; Brendolan A; Ronco C
    Kidney Int Suppl; 1998 May; 66():S186-9. PubMed ID: 9573601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of platelet-activating factor in inflammation and sepsis: mechanisms and kinetics of removal in extracorporeal treatments.
    Tetta C; Mariano F; Buades J; Ronco C; Wratten ML; Camussi G
    Am J Kidney Dis; 1997 Nov; 30(5 Suppl 4):S57-65. PubMed ID: 9372980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine removal on extracorporeal life support for treatment of acute endotoxemia: a randomized controlled animal study.
    Weerwind PW; van der Veen FH; Gelsomino S; Nagaraj NG; Parise O; Lorusso R; Gensini GF; Maessen JG
    Int J Cardiol; 2013 Oct; 168(5):4699-704. PubMed ID: 23954008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood and plasma treatments: the rationale of high-volume hemofiltration.
    Honoré PM; Joannes-Boyau O; Gressens B
    Contrib Nephrol; 2007; 156():387-95. PubMed ID: 17464149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption.
    Tetta C; Cavaillon JM; Schulze M; Ronco C; Ghezzi PM; Camussi G; Serra AM; Curti F; Lonnemann G
    Nephrol Dial Transplant; 1998 Jun; 13(6):1458-64. PubMed ID: 9641176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-6 adsorption dynamics in hemoadsorption beads studied using confocal laser scanning microscopy.
    Kimmel JD; Gibson GA; Watkins SC; Kellum JA; Federspiel WJ
    J Biomed Mater Res B Appl Biomater; 2010 Feb; 92(2):390-6. PubMed ID: 19904819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous hemoadsorption with a cytokine adsorber during sepsis - a review of the literature.
    Houschyar KS; Pyles MN; Rein S; Nietzschmann I; Duscher D; Maan ZN; Weissenberg K; Philipps HM; Strauss C; Reichelt B; Siemers F
    Int J Artif Organs; 2017 May; 40(5):205-211. PubMed ID: 28525674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of hemofiltration with PEPA membrane for IL-6 removal in a rat sepsis model.
    Maeda H; Tomisawa N; Jimbo Y; Harii N; Matsuda K
    J Artif Organs; 2017 Dec; 20(4):335-340. PubMed ID: 28894963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad adsorption of sepsis-related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb® sorbent porous polymer beads.
    Gruda MC; Ruggeberg KG; O'Sullivan P; Guliashvili T; Scheirer AR; Golobish TD; Capponi VJ; Chan PP
    PLoS One; 2018; 13(1):e0191676. PubMed ID: 29370247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hemoadsorption on cytokine removal and short-term survival in septic rats.
    Peng ZY; Carter MJ; Kellum JA
    Crit Care Med; 2008 May; 36(5):1573-7. PubMed ID: 18434884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why do we need extracorporeal blood purification for sepsis and septic shock?
    Simoni J
    Artif Organs; 2019 May; 43(5):444-447. PubMed ID: 30908693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.